Citations

Showing 10 of 108119 citations.

Knee Abduction and Internal Rotation Moments Increase ACL Force During Landing Through the Posterior Slope of the Tibia
Navacchia, Alessandro , Bates, Nathaniel A. , Schilaty, Nathan D. , Krych, Aaron J. , Hewett, Timothy E. , Krych, Aaron J , Schilaty, Nathan D , Bates, Nathaniel A

Mayo Clinic

Journal of Orthopaedic Research | April 12, 2019 | Volume: 37 | Issue: 8 | Pages: 1730-1742

10.1002/jor.24313 | PMID 30977558 Get It

ABSTRACTThe mechanism underlying non‐contact anterior cruciate ligament (ACL) injury is multi‐factorial and still an object of debate. Computational models, in combination with in vivo and cadaveric studies, can provide valuable insight into the contribution of the different factors involved. The goal of this study was to validate four knee finite element models (two males and two females) to kinematic and strain data collected in vitro with an impact‐driven simulator and use them to assess how secondary external knee loads (knee abduction moment [KAM], anterior shear force, and internal rotation torque [ITR]) affect tibiofemoral contact forces and ACL force during impact. Four subject‐specific knee models were developed from specimen computed tomography and magnetic resonance imaging. Patellofemoral and tibiofemoral ligament properties were calibrated to match experimentally measured kinematics and ligament strain. Average root mean square errors and correlations between experimental and model‐predicted knee kinematics were below 1.5 mm and 2°, and above 0.75, respectively. Similar errors and correlations were obtained for ACL strain (< 2% and > 0.9). Model‐predicted ACL forces were highly correlated with the anterior component of the tibiofemoral contact force on the lateral plateau occurring during impact (r = 0.99), which was increased by larger KAM and ITR through the posterior tibial slope and a larger contact force on the lateral side. This study provides a better understanding of the mechanism through which secondary external knee loads increase ACL injury risk during landing. © 2019 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 37:1730–1742, 2019
Epigenetics as a New Frontier in Orthopedic Regenerative Medicine and Oncology
Wijnen, André J. van , van Wijnen, Andre J , Westendorf, Jennifer J.

Mayo Clinic

Journal of Orthopaedic Research | April 12, 2019 | Volume: 37 | Issue: 7 | Pages: 1465-1474

10.1002/jor.24305 | PMID 30977555 Get It

ABSTRACTSkeletal regenerative medicine aims to repair or regenerate skeletal tissues using pharmacotherapies, cell‐based treatments, and/or surgical interventions. The field is guided by biological principles active during development, wound healing, aging, and carcinogenesis. Skeletal development and tissue maintenance in adults represent highly intricate biological processes that require continuous adjustments in the expression of cell type‐specific genes that generate, remodel, and repair the skeletal extracellular matrix. Errors in these processes can facilitate musculoskeletal disease including cancers or injury. The fundamental molecular mechanisms by which cell type‐specific patterns in gene expression are established and retained during successive mitotic divisions require epigenetic control, which we review here. We focus on epigenetic regulatory proteins that control the mammalian epigenome at the level of chromatin with emphasis on proteins that are amenable to drug intervention to mitigate skeletal tissue degeneration (e.g., osteoarthritis and osteoporosis). We highlight recent findings on a number of druggable epigenetic regulators, including DNA methyltransferases (e.g., DNMT1, DNMT3A, and DNMT3B) and hydroxylases (e.g., TET1, TET2, and TET3), histone methyltransferases (e.g., EZH1, EZH2, and DOT1L) as well as histone deacetylases (e.g., HDAC3, HDAC4, and HDAC7) and histone acetyl readers (e.g., BRD4) in relation to the development of bone or cartilage regenerative drug therapies. We also review how histone mutations lead to epigenomic catastrophe and cause musculoskeletal tumors. The combined body of molecular and genetic studies focusing on epigenetic regulators indicates that these proteins are critical for normal skeletogenesis and viable candidate drug targets for short‐term local pharmacological strategies to mitigate musculoskeletal tissue degeneration. © 2019 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 37:1465–1474, 2019.
Incremental costs of high intensive care utilisation in patients hospitalised with heart failure
Tran, Dat T. , Schnell, Gregory, Kaul, Padma , Diepen, Sean van , Ezekowitz, Justin A. , Wiley, Brandon M. , Morrow, David A. , McAlister, Finlay A.

Mayo Clinic

European Heart Journal: Acute Cardiovascular Care | April 12, 2019 | Volume: 8 | Issue: 7 | Pages: 660-666

10.1177/2048872619845282 | PMID 30977391 Get It

Aims: Registries have reported large inter-hospital differences in intensive care unit admission rates for patients with acute heart failure, but little is known about the potential economic impact of over-admission of low-risk patients with heart failure to higher cost intensive care units. We described the variability in intensive care unit admission practices, the provision of critical care therapies, and estimated the potential national cost savings if all hospitals adopted low intensive care unit admission practices for patients admitted with heart failure. Methods: Using a national population health dataset, we identified 349,693 heart failure admission hospitalisations with a primary diagnosis of heart failure between 2007 and 2016. Hospitals were categorised as low (first quartile), medium (second and third quartile) and high (fourth quartiles) intensive care unit utilisation. Results: The mean intensive care unit admission rate was 16.4% (inter-hospital range 0.3–51%) including 5.4% in low, 14.5% in medium and 30% in high utilisation hospitals. Intensive care unit therapies in low, medium and high intensive care unit utilisation hospitals were 54.5%, 45.1% and 24.1% ( P<0.001), respectively and the inhospital mortality rate was not significantly different. The proportion of hospital costs incurred by intensive care unit care was 7.8% in low, 19.8% in medium and 28.2% in high ( P<0.001) admission hospitals. The potential cost savings of altering intensive care unit utilisation practices for patients with heart failure was CAN$234.8m over the study period. Conclusions: In a national cohort of patients hospitalised with heart failure, we observed that low intensive care unit utilisation centres had lower hospital costs with no differences in mortality rates. The development of standardised admission criteria for high-cost and high acuity intensive care unit beds could reduce costs to the healthcare system.
Letter: meta‐analysis of prebiotics, probiotics, synbiotics and antibiotics in IBS. Authors’ reply
Ford, Alexander C. , Harris, Lucinda A. , Lacy, Brian E. , Quigley, Eamonn M.M. , Ford, Alexander C , Quigley, Eamonn M M , Moayyedi, Paul

Mayo Clinic

Alimentary Pharmacology & Therapeutics | April 12, 2019 | Volume: 49 | Issue: 9 | Pages: 1254-1255

10.1111/apt.15234 | PMID 30977174 Get It

Linked ContentThis article is linked to Ford et al and Sun et al papers. To view these articles, visit https://doi.org/10.1111/apt.15001 and https://doi.org/10.1111/apt.15230.
Spiritual Care at the End of Life: Does Educational Intervention Focused on a Broad Definition of Spirituality Increase Utilization of Chaplain Spiritual Support in Hospice?
Soroka, Jacek T. , Collins, Lori , Creech, Gary, Kutcher, Gregory R., Menne, Katherine R., Petzel, Brianna L., Collins, Lori A, Collins, Lori A.

Mayo Clinic

Journal of Palliative Medicine | April 12, 2019 | Volume: 22 | Issue: 8 | Pages: 939-944

10.1089/jpm.2018.0579 | PMID 30977717 Get It

Abstract Background: Research shows that religion and spirituality are important when persons cope with serious and life-threatening illness. Patients who receive good spiritual care report greater quality of life and better coping, and such support is strongly associated with greater well-being, hope, optimism, and reduction of despair at end of life. Despite these benefits, evidence shows that many patients and caregivers (P/C) refuse spiritual care when a hospice team offers it, possibly resulting in unnecessary suffering. Objective: To better understand what contributes to spiritual support acceptance in hospice care. Design: Quasi-experimental quantitative study. Setting/Subjects: 200 patients admitted to hospice. Measurements: Participants were divided equally into intervention and control arms. Control participants received standard information about the availability of chaplain support and an offer for referral to chaplain services. Intervention participants received educational intervention that explained hospice chaplain services and the evidence-based benefits of spiritual support. The association of chaplain acceptance was measured with treatment group, patient age, disease, church affiliation and support, sex, bereavement risk, and place of residence. Results: Among intervention participants, 64 (64%) accepted spiritual support versus 52 (52%) of control participants. The intervention arm's acceptance rate was higher than the control arm after adjustment for other variables. The variables associated with acceptance were age, primary diagnosis, and place of residence. Conclusions: This research suggests that educational intervention that explains spiritual care in hospice and its benefits contributes importantly to greater acceptance and allows P/C to gain the benefits of spiritual support during end-of-life care.
Outcome of fetuses with lower urinary tract obstruction and normal amniotic fluid volume in second trimester of pregnancy
Nassr, Ahmed A. , Shamshirsaz, Alireza A. , Espinoza, Jimmy , Koh, Chester J. , Roth, David R. , Angelo, Joseph , Mandy, George T., Braun, Michael , Belfort, Michael A. , Nassr, A A , Espinoza, J , Belfort, M A , Erfani, Hadi , Cortes, Magda Sanz , Ruano, Rodrigo

Mayo Clinic

Ultrasound in Obstetrics & Gynecology | April 12, 2019 | Volume: 54 | Issue: 4 | Pages: 500-505

10.1002/uog.20288 | PMID 30977189 Get It

ABSTRACTObjectiveCongenital lower urinary tract obstruction (LUTO) is a rare condition with high perinatal mortality and morbidity when associated with severe oligohydramnios or anhydramnios in the second trimester of pregnancy. Severe pulmonary hypoplasia and end‐stage renal disease are the underlying causes of poor neonatal outcome in these cases. However, little is known about the subset of fetal LUTO that is associated with a normal volume of amniotic fluid at midgestation. The objective of the current study was to describe the natural history, underlying causes, survival and postnatal renal function outcomes in pregnancies with fetal LUTO and normal amniotic fluid volume during the second trimester of pregnancy.MethodsThis was a retrospective study of all pregnancies with fetal LUTO and normal amniotic fluid volume in the second trimester that received prenatal and postnatal care at our quaternary care institution between 2013 and 2017. Data on demographic characteristics, fetal interventions, perinatal survival, need for neonatal respiratory support, postnatal renal function and need for dialysis at the age of 1 and 24 months were analyzed.ResultsOf the 18 fetuses that met the study criteria, 17 (94.4%) survived the perinatal period. Eleven (61.1%) pregnancies developed oligohydramnios in the third trimester, six of which were eligible for and underwent fetal intervention with vesicoamniotic shunt placement, which was performed successfully in all six cases. Two (11.1%) neonates required respiratory support owing to pulmonary hypoplasia. At the age of 2 years, 14 children had follow‐up information available, two (14.3%) of whom had normal renal function, eight (57.1%) had developed some degree of chronic kidney disease (Stage 1–4) and four (28.6%) had developed end‐stage renal disease (ESRD), including two who had already manifested ESRD in the neonatal period.ConclusionsMost fetuses diagnosed prenatally with LUTO that is associated with a normal volume of amniotic fluid at midgestation will have a favorable outcome in terms of perinatal survival and few will need long‐term respiratory support. However, these children are still at increased risk for chronic renal disease, ESRD and need for renal replacement therapy. Larger multicenter studies are needed to characterize the prenatal factors associated with postnatal renal function, and to investigate the role of fetal intervention in the group of fetuses that present with late‐onset oligohydramnios and evidence of preserved fetal renal function. Copyright © 2019 ISUOG. Published by John Wiley & Sons Ltd.
Impact of measurement error on predicting population-based inpatient glucose control
Saulnier, George E., Castro, Janna C. , Cook, Curtiss B.

Mayo Clinic

Future Science OA | April 12, 2019 | Volume: No volume available | Issue: No issue available | Pages: FSO388

10.4155/fsoa-2019-0003 Get It

2018 International Consensus Meeting on Musculoskeletal Infection: Research Priorities from the General Assembly Questions
Schwarz, Edward M. , Gehrke, Thorsten , Aiyer, Amiethab A. , Battenberg, Andrew K. , Brown, Scot , Callaghan, John J. , Egol, Kenneth A. , Garrigues, Grant E. , Ghert, Michelle , Goswami, Karan , Hammound, Sommer, McLaren, A. C. , Mont, Michael A. , Namdari, Surena , Obremskey, William T. , O’Toole, Robert V. , Raikin, Steven M. , Restrepo, Camilo , Ricciardi, Benjamin F. , Saeed, Kordo , Shohat, Noam , Tan, Timothy L. , Thirukumaran, Caroline P. , Winters, Brian S., Sanchez-Sotelo, Joaquin, Schwarz, Edward M , Parvizi, Javad , Gehrke, Thorsten A. , Çıtak, Mustafa , Green, Andrew , Kates, Stephen L. , Sánchez‐Sotelo, Joaquín

Mayo Clinic

Journal of Orthopaedic Research | April 12, 2019 | Volume: 37 | Issue: 5 | Pages: 997-1006

10.1002/jor.24293 | PMID 30977537 Get It

ABSTRACT Musculoskeletal infections (MSKI) remain the bane of orthopedic surgery, and result in grievous illness and inordinate costs that threaten healthcare systems. As prevention, diagnosis, and treatment has remained largely unchanged over the last 50 years, a 2nd International Consensus Meeting on Musculoskeletal Infection (ICM 2018, https://icmphilly.com ) was completed. Questions pertaining to all areas of MSKI were extensively researched to prepare recommendations, which were discussed and voted on by the delegates using the Delphi methodology. The questions, including the General Assembly (GA) results, have been published ( GA questions ). However, as critical outcomes include: (i) incidence and cost data that substantiate the problems, and (ii) establishment of research priorities; an ICM 2018 research workgroup (RW) was assembled to accomplish these tasks. Here, we present the result of the RW consensus on the current and projected incidence of infection, and the costs per patient, for all orthopedic subspecialties, which range from 0.1% to 30%, and $17,000 to $150,000. The RW also identified the most important research questions. The Delphi methodology was utilized to initially derive four objective criteria to define a subset of the 164 GA questions that are high priority for future research. Thirty‐eight questions (23% of all GA questions) achieved the requisite > 70% agreement vote, and are highlighted in this Consensus article within six thematic categories: acute versus chronic infection, host immunity, antibiotics, diagnosis, research caveats, and modifiable factors. Finally, the RW emphasizes that without appropriate funding to address these high priority research questions, a 3rd ICM on MSKI to address similar issues at greater cost is inevitable.
Ineffective esophageal motility: Concepts, future directions, and conclusions from the Stanford 2018 symposium
Gyawali, C. Prakash , Carlson, Dustin A. , Hawn, Mary T. , Katzka, David A. , Pandolfino, John E. , Penagini, Roberto , Roman, Sabine , Savarino, Edoardo , Tatum, Roger P. , Vaezi, Michel, Clarke, John O. , Triadafilopoulos, George , Carlson, Dustin A , Penagini, Roberto , Roman, S , Clarke, J , Gyawali, C P , Triadafilopoulos, George , Savarino, Edoardo , Sifrim, Daniel , Vaezi, Michael F.

Mayo Clinic

Neurogastroenterology & Motility | April 12, 2019 | Volume: 31 | Issue: 9 | Pages: No page available

10.1111/nmo.13584 | PMID 30974032 Get It

AbstractBackgroundIneffective esophageal motility (IEM) is a heterogenous minor motility disorder diagnosed when ≥50% ineffective peristaltic sequences (distal contractile integral <450 mm Hg cm s) coexist with normal lower esophageal sphincter relaxation (integrated relaxation pressure < upper limit of normal) on esophageal high‐resolution manometry (HRM). Ineffective esophageal motility is not consistently related to disease states or symptoms and may be seen in asymptomatic healthy individuals.PurposeA 1‐day symposium of esophageal experts reviewed existing literature on IEM, and this review represents the conclusions from the symposium. Severe IEM (>70% ineffective sequences) is associated with higher esophageal reflux burden, particularly while supine, but milder variants do not progress over time or consistently impact quality of life. Ineffective esophageal motility can be further characterized using provocative maneuvers during HRM, especially multiple rapid swallows, where augmentation of smooth muscle contraction defines contraction reserve. The presence of contraction reserve may predict better prognosis, lesser reflux burden and confidence in a standard fundoplication for surgical management of reflux. Other provocative maneuvers (solid swallows, standardized test meal, rapid drink challenge) are useful to characterize bolus transit in IEM. No effective pharmacotherapy exists, and current managements target symptoms and concurrent reflux. Novel testing modalities (baseline and mucosal impedance, functional lumen imaging probe) show promise in elucidating pathophysiology and stratifying IEM phenotypes. Specific prokinetic agents targeting esophageal smooth muscle need to be developed for precision management.
A case of multiple myeloma presenting with uric acid kidney stones
Salameh, Hassan, Hamadah, Abdurrahman , Chiu, April , Leung, Nelson , Leung, Nelson , Sirac, Christophe , Bender, Sébastien , Cornell, Lynn D. , Fornoni, Alessia

Mayo Clinic

Journal of Onco-Nephrology | April 12, 2019 | Volume: 3 | Issue: 2 | Pages: 98-102

10.1177/2399369319841388 Get It

Kidney disease is common in patients with multiple myeloma. Patients often present with acute kidney failure most commonly the result of light chain cast nephropathy. Presentation can also be in the form of nephrotic syndrome associated with immunoglobulin light chain amyloidosis or monoclonal immunoglobulin deposition disease and tubulopathy as in acquired light chain Fanconi syndrome. We present a case of a 56-year-old male with multiple myeloma who presented with chronic kidney disease and uric acid stones. Chemical analysis of the nephrolithiasis showed it to be entirely composed of uric acid. Fractional excretion of uric acid was elevated at 35.9%. Kidney biopsy was consistent with light chain proximal tubulopathy. Bone marrow biopsy showed 30% kappa light chain–restricted plasma cells. Genetic sequencing identified the light chain to be from the Vk1-33 subgroup. The patient was treated with bortezomib, cyclophosphamide, and dexamethasone, with improvement of his kidney function. This case illustrates a rare presentation of multiple myeloma.